E-LIB Suche - Ergebnisse für: Postow, Michael A - Sprache DE

OpenAccess-Volltexte X

Personensuche X

Sortierung: Relevanz

Sortierung: Jahr

1

A topic modeling approach reveals the dynamic T cell compos..:

Peng, Xiyu ; Lee, Jasme ; Adamow, Matthew...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475788/. , 2023

Link: http://www.ncbi.nlm.nih...

2

Eganelisib, a First-in-Class PI3K- [Formula: see text] Inhi..:

Hong, David S ; Postow, Michael ; Chmielowski, Bartosz...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388696/. , 2023

Link: http://www.ncbi.nlm.nih...

3

Efficacy of immunotherapy for melanoma brain metastases in ..:

Tringale, Kathryn R ; Reiner, Anne S ; Sehgal, Ryka R...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996406/. , 2023

Link: http://www.ncbi.nlm.nih...

4

Eganelisib, a First-in-Class PI3Kγ Inhibitor, in Patients w..:

Hong, David S ; Postow, Michael ; Chmielowski, Bartosz...
qt6h50s9vr. , 2023

Link: https://escholarship.org..

5

Uncovering the hidden structure of dynamic T cell compositi..:

Peng, Xiyu ; Lee, Jasme ; Adamow, Matthew...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10168231/. , 2023

Link: http://www.ncbi.nlm.nih...

6

Concurrent immune checkpoint inhibition and selective immun..:

Badran, Yousef R ; Zou, Fangwen ; Durbin, Sienna M...
qt3b73q7fd. , 2023

Link: https://escholarship.org..

7

Phase Ib Trial of Phenformin in Patients with V600-mutated ..:

Chapman, Paul B ; Klang, Mark ; Postow, Michael A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695100/. , 2023

Link: http://www.ncbi.nlm.nih...

8

Decision-Making and Health-Related Quality of Life in Patie..:

Atkinson, Thomas M ; Hay, Jennifer L ; Young Kim, Soo...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10078893/. , 2023

Link: http://www.ncbi.nlm.nih...

9

Author Correction: Neoadjuvant relatlimab and nivolumab in ..:

Amaria, Rodabe N ; Postow, Michael ; Burton, Elizabeth M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10033416/. , 2023

Link: http://www.ncbi.nlm.nih...

10

Exocrine Pancreatic Insufficiency Induced by Immune Checkpo..:

Satish, Deepika ; Lin, I-Hsin ; Flory, James...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10712706/. , 2023

Link: http://www.ncbi.nlm.nih...

11

Concurrent immune checkpoint inhibition and selective immun..:

Badran, Yousef R ; Zou, Fangwen ; Durbin, Sienna M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314704/. , 2023

Link: http://www.ncbi.nlm.nih...

12

Efficacy of Infliximab Dose Escalation in Patients with Ref..:

Harris, Jessica P ; Postow, Michael A ; Faleck, David M
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982418/. , 2022

Link: http://www.ncbi.nlm.nih...

13

The "Great Debate" at Immunotherapy Bridge 2021, December 1..:

Ascierto, Paolo A ; Butterfield, Lisa H ; Finn, Olivera J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022317/. , 2022

Link: http://www.ncbi.nlm.nih...

14

Ipilimumab alone or in combination with nivolumab in patien..:

Friedman, Claire F ; Spencer, Christine ; Cabanski, Christopher R...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788323/. , 2022

Link: http://www.ncbi.nlm.nih...

15

Early Readout on Overall Survival of Patients With Melanoma..:

Dercle, Laurent ; Zhao, Binsheng ; Gönen, Mithat...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778619/. , 2022

Link: http://www.ncbi.nlm.nih...

1-15